Clinical Inertia in Diabetes: Why Embrace Long-Acting Insulins?

Published: Jan. 28, 2019, 3:54 p.m.

In part 2 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, discusses the benefits of long-acting insulins and barriers that may prevent more widespread implementation of these therapies. For more, visit www.consultant360.com.